Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 EUR | +0.70% |
|
-11.25% | -12.88% |
06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
Sales 2024 * | 750K 693K 58.66M | Sales 2025 * | 750K 693K 58.66M | Capitalization | 121M 112M 9.47B |
---|---|---|---|---|---|
Net income 2024 * | -143M -132M -11.18B | Net income 2025 * | -146M -135M -11.42B | EV / Sales 2024 * | 161 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 161 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-1.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.84% |
Latest transcript on I-Mab
1 week | -11.25% | ||
Current month | -8.97% | ||
1 month | -0.70% | ||
3 months | -14.97% | ||
6 months | -32.38% | ||
Current year | -12.88% |
![Extreme 1.42](/images/extremecours_fleche.png)
![Extreme 1.42](/images/extremecours_fleche.png)
![Extreme 1.1](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Rajkumar Kannan
CEO | Chief Executive Officer | 61 | 21/06/23 |
Jerry Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yi Fei Zhu
PRN | Corporate Officer/Principal | 55 | 09/08/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chia Hung Yang
BRD | Director/Board Member | 61 | 31/12/19 |
Pamela Klein
CHM | Chairman | 63 | 31/12/19 |
Shuai Chen
BRD | Director/Board Member | 50 | 31/03/23 |
Date | Price | Change |
---|---|---|
05/07/24 | 1.42 | 0.00% |
04/07/24 | 1.42 | -2.07% |
03/07/24 | 1.45 | -2.68% |
02/07/24 | 1.49 | +0.68% |
01/07/24 | 1.48 | -5.13% |
Delayed Quote Börse Stuttgart, July 05, 2024 at 07:04 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.07% | 809B | |
+39.62% | 624B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.40% | 240B | |
+0.78% | 219B | |
+14.69% | 220B | |
+7.42% | 166B |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock